These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1927767

  • 21. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N, Arima K, Sugimura Y.
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH, Chen J, Wu CY, Cheng AL, Pu YS.
    Anticancer Res; 2001 Sep; 21(1B):711-5. PubMed ID: 11299831
    [Abstract] [Full Text] [Related]

  • 23. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M, Kotake T.
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [Abstract] [Full Text] [Related]

  • 24. [The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
    Hattori T, Satoh M, Terashima Y, Nishimura T, Akimoto M.
    Hinyokika Kiyo; 1991 Sep; 37(9):995-8. PubMed ID: 1785427
    [Abstract] [Full Text] [Related]

  • 25. [Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)].
    Bellmunt Molins J, Ribas A, Albanell J, Lorente Garín JA, de Torres Mateos JA, Morote Robles J, López Palacios MA, Banús Gassol JM, Casado Cobo S, Eres N, Solé Calvo LA.
    Arch Esp Urol; 1996 Jun; 49(5):465-72. PubMed ID: 8766083
    [Abstract] [Full Text] [Related]

  • 26. [Two cases of urothelial cancer responsive to high-dose-intensity methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy].
    Fukuda H, Mitsumori K, Minagawa S, Kumazawa T, Tadachi K, Iinuma M, Satoh S, Satoh K, Habuchi T, Kato T.
    Hinyokika Kiyo; 2005 Feb; 51(2):113-6. PubMed ID: 15773365
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
    Sternberg CN, Yagoda A, Scher HI.
    Prog Clin Biol Res; 1988 Feb; 277():45-51. PubMed ID: 3054909
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
    Wei CH, Hsieh RK, Chiou TJ, Chen KK, Chang LS, Chen PM.
    J Urol; 1996 Jan; 155(1):118-21. PubMed ID: 7490806
    [Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
    Mikami K, Nakagawa S, Takada H, Ebisui K, Sugimoto K, Watanabe H, Maegawa M, Nakao M.
    Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
    [Abstract] [Full Text] [Related]

  • 32. [A case of right renal pelvic and ureter cancer with hepatic metastasis showing complete response by M-VAC].
    Sumiyoshi Y, Akiyama K, Yano M.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1521-3. PubMed ID: 2389946
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Quality of life in patients with advanced bladder cancer treated by tumorectomy and systemic adjuvant polychemotherapy (M-VAC). Our experience in 14 cases.
    Valente R, Marini F, Signori GB, Martino F.
    Arch Esp Urol; 1989 Aug; 42(1):87-9. PubMed ID: 2712609
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma].
    Narita S, Nakano M, Matsuzaki M, Watanabe J, Morikawa H, Murata H, Oda H, Komatsu H.
    Hinyokika Kiyo; 2005 Mar; 51(3):155-8. PubMed ID: 15852667
    [Abstract] [Full Text] [Related]

  • 37. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
    Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS.
    J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
    [Abstract] [Full Text] [Related]

  • 38. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S, Ito T, Aizawa T, Namiki K, Ohno Y, Yamamoto S, Ishibashi K, Miki M, Yamauchi T, Kawai T.
    Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.